Baussano, I, et al.
Tuberculosis among health care workers. Emerging Infectious Diseases
2011; 17: 488–494.
Sepkowitz, KA. Tuberculosis and the health care worker: a historical perspective. Annals of Internal Medicine
1994; 120: 71–79.
Pai, M, Sotgiu, G. Diagnostics for latent TB infection: incremental, not transformative progress. European Respiratory Journal
2016; 47: 704–706.
Zwerling, A, et al.
The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Medicine
2011; 8: e1001012.
Rodriguez, DA, et al.
Monitoring delays in diagnosis of pulmonary tuberculosis in eight cities in Colombia. Pan American Journal of Public Health
2016; 39: 12–18.
Castillo, D, Fadul, S. Tuberculosis in health personnel, Colombia, 2008 to 2012. Bogotá, Colombia:
National Epidemiological Fortnightly Report
2013; 2: 12–30.
Joseph, L, Gyorkos, TW, Coupal, L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. American Journal of Epidemiology
1995; 141: 263–272.
Tebruegge, M, et al.
Shortage of purified protein derivative for tuberculosis testing. Lancet
2014; 384: 2026.
Anon. National shortage of purified-protein derivative tuberculin products. Morbidity and Mortality Weekly Report
2013; 62: 312.
Pai, M, Rodrigues, C. Management of latent tuberculosis infection: an evidence-based approach. Lung India
2015; 32: 205–207.
Zyl-Smit, RNv, et al.
Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing. American Journal of Respiratory and Critical Care Medicine
2009; 180: 49–58.
Lee, E, Holzman, RS. Evolution and current use of the tuberculin test. Clinical Infectious Diseases
2002; 34: 365–370.
Menzies, D. Interpretation of repeated tuberculin tests. American Journal of Respiratory and Critical Care Medicine
1999; 159: 15–21.
Fleisss, J. Statistical Methods for Rates and Proportions. New York: Wiley, 1981.
Ling, D, et al.
A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard. BMC Medical Research Methodology
2014; 14: 67.
Wang, Z, Dendukuri, N, Joseph, L. Understanding the effects of conditional dependence in research studies involving imperfect diagnostic tests. Statistics in Medicine
Pai, M, et al.
Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models. International Journal of Tuberculosis and Lung Disease
2008; 12: 895–902.
Menzies, D, et al.
Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. International Journal of Tuberculosis and Lung Disease
2008; 12: 498–505.
World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva: World Health Organization, 2015.
Getahun, H, et al.
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal
2015; 46: 1563–1576.
Joshi, R, et al.
Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Medicine
2006; 3: e494.
Nienhaus, A, et al.
IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers. Expert Review of Anti-infective Therapy
2013; 11: 37–48.
Lamberti, M, et al.
Tuberculin skin test and Quantiferon test agreement and influencing factors in tuberculosis screening of healthcare workers: a systematic review and meta-analysis. Journal of Occupational Medicine and Toxicology
2015; 10: 1–13.
del Corral, H, et al.
IFNγ response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS ONE
2009; 4: e8257.
A. Whitaker, J, et al.
Prevalence and incidence of latent tuberculosis infection in Georgian healthcare workers. PLoS ONE
2013; 8: e58202.
Pai, M, et al.
Mycobacterium tuberculosis infection in health care workers in rural India. Journal of the American Medical Association
2005; 293: 2746–2755.
Pai, M, et al.
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clinical Microbiology Reviews
2014; 27: 3–20.
Dorman, SE, et al.
Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. American Journal of Respiratory and Critical Care Medicine
2014; 189: 77–87.
Zwerling, A, et al.
TB screening in Canadian health care workers using interferon-gamma release assays. PLoS ONE
2012; 7: e43014.
Mazurek, GH, et al.
Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection – United States, 2010. Morbidity and Mortality Weekly Report
2010; 59: 1–25.
Torrance-Rynard, VL, Walter, SD. Effects of dependent errors in the assessment of diagnostic test performance. Statistics in Medicine
1997; 16: 2157–2175.
Trajman, A, Steffen, RE, Menzies, D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulmonary Medicine
2013; 2013: 11.
Menzies, D, Joshi, R, Pai, M. Risk of tuberculosis infection and disease associated with work in health care settings. International Journal of Tuberculosis and Lung Disease
2007; 11: 593e605.
Ochoa, J, et al.
Simulation of risk of tuberculosis infection in healthcare workers in hospitals of an intermediate incidence country. Epidemiology and Infection
2015; 143: 2639–2647.
Barrera, E, Livchits, V, Nardell, E. F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy. International Journal of Tuberculosis and Lung Disease
2015; 19: 381–384.